Bygdeman and Swahn (1996)1414 Bygdeman M, Swahn ML. Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women. Maturitas. 1996;23(03):259–263. Doi: 10.1016/03785122(95)00955-8 https://doi.org/10.1016/0378-5122(95)009...
|
fx3 |
fx2 |
fx1 |
fx1 |
fx3 |
fx3 |
fx2 |
Loprinzi et al. (1997)1515 Loprinzi CL, Abu-Ghazaleh S, Sloan JA, vanHaelst-Pisani C, Hammer AM, Rowland KM, et al. Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer. J Clin Oncol. 1997;15 (03):969–973 Doi: 10.1200/jco.1997.15.3.969 https://doi.org/10.1200/jco.1997.15.3.96...
|
fx2 |
fx2 |
fx2 |
fx2 |
fx3 |
fx3 |
fx2 |
Balk et al. (2002)3232 Balk JL, Whiteside DA, Naus G, DeFerrari E, Roberts JM. A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometrium. J Soc Gynecol Investig. 2002;9(04): 238–242. Doi: 10.1177/107155760200900410 https://doi.org/10.1177/1071557602009004...
|
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx2 |
Labrie et al. (2009)4545 Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, et al. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause. 2009;16(05):923–931 Doi: 10.1097/gme.0-b013e31819e85c6 https://doi.org/10.1097/gme.0b013e31819e...
|
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx2 |
Bachmann and Komi (2010)5252 Bachmann GA, Komi JOOspemifene Study Group. Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study. Menopause. 2010;17(03):480–486. Doi: 10.1097/gme.0b013e3181c1ac01 https://doi.org/10.1097/gme.0b013e3181c1...
|
fx3 |
fx3 |
fx3 |
fx3 |
fx2 |
fx3 |
fx3 |
Oh et al. (2010)3333 Oh KJ, Chae MJ, Lee HS, Hong HD, Park K. Effects of Korean red ginseng on sexual arousal in menopausal women: placebo-controlled, double-blind crossover clinical study. J Sex Med. 2010;7 (4 Pt 1):1469–1477. Doi: 10.1111/j.1743-6109.2009.01700.x https://doi.org/10.1111/j.1743-6109.2009...
|
fx3 |
fx3 |
fx3 |
fx2 |
fx2 |
fx3 |
fx2 |
Raghunandan et al. (2010)1616 Raghunandan C, Agrawal S, Dubey P, Choudhury M, Jain A. A comparative study of the effects of local estrogenwith or without local testosterone on vulvovaginal and sexual dysfunction in postmenopausal women. J Sex Med. 2010;7(03):1284–1290. Doi: 10.1111/j.1743-6109.2009.01667.x https://doi.org/10.1111/j.1743-6109.2009...
|
fx3 |
fx2 |
fx1 |
fx1 |
fx3 |
fx3 |
fx1 |
Ekin et al. (2011)6767 Ekin M, Yaºar L, Savan K, Temur M, Uhri M, Gencer I, et al. The comparison of hyaluronic acid vaginal tablets with estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Arch Gynecol Obstet. 2011;283(03):539–543 Doi: 10.1007/s00404-010-1382-8 https://doi.org/10.1007/s00404-010-1382-...
|
fx3 |
fx2 |
fx1 |
fx1 |
fx3 |
fx3 |
fx2 |
Genazzani et al. (2011)4646 Genazzani AR, StomatiM, Valentino V, PluchinoN, Potì E, Casarosa E, et al. Effect of 1-year, low-dose DHEA therapy on climacteric symptoms and female sexuality. Climacteric. 2011;14(06): 661–668 Doi: 10.3109/13697137.2011.579649 https://doi.org/10.3109/13697137.2011.57...
|
fx3 |
fx3 |
fx1 |
fx1 |
fx3 |
fx3 |
fx3 |
Jonasson et al. (2011)6161 Jonasson AF, Edwall L, Uvnäs-Moberg K. Topical oxytocin reverses vaginal atrophy in postmenopausal women: a double-blind randomized pilot study. Menopause Int. 2011;17(04):120–125. Doi: 10.1258/mi.2011.011030 https://doi.org/10.1258/mi.2011.011030...
|
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx2 |
Labrie et al. (2011)2727 Labrie F, Archer DF, Bouchard C, Fortier M, Cusan L, Gomez JL, et al. Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia. Climacteric. 2011;14(02): 282–288 Doi: 10.3109/13697137.2010.535226 https://doi.org/10.3109/13697137.2010.53...
|
fx2 |
fx2 |
fx2 |
fx2 |
fx3 |
fx3 |
fx2 |
Le Donne et al. (2011)2828 Le Donne M, Caruso C, Mancuso A, Costa G, Iemmo R, Pizzimenti G, et al. The effect of vaginally administered genistein in comparison with hyaluronic acid on atrophic epithelium in postmenopause. Arch Gynecol Obstet. 2011;283(06):1319–1323 Doi: 10.1007/s00404-010-1545-7 https://doi.org/10.1007/s00404-010-1545-...
|
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx2 |
Lee et al. (2011)1717 Lee YK, Chung HH, KimJW, ParkNH, Song YS, Kang SB. Vaginal pHbalanced gel for the control of atrophic vaginitis among breast cancer survivors: a randomized controlled trial. Obstet Gynecol. 2011;117(04):922–927. Doi: 10.1097/aog.0b013e3182118790 https://doi.org/10.1097/aog.0b013e318211...
|
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx2 |
Loprinzi et al. (2011)1818 Loprinzi CL, Balcueva EP, Liu H, Sloan JA, Kottschade LA, Stella PJ, et al. A phase III randomized, double-blind, placebo-controlled study of pilocarpine for vaginal dryness: North Central Cancer Treatment group study N04CA. J Support Oncol. 2011;9(03): 105–112 Doi: 10.1016/j.suponc.2011.02.005 https://doi.org/10.1016/j.suponc.2011.02...
|
fx3 |
fx3 |
fx3 |
fx2 |
fx3 |
fx3 |
fx3 |
Amato et al. (2013)3434 Amato P, Young RL, Steinberg FM, Murray MJ, Lewis RD, Cramer MA, et al. Effect of soy isoflavone supplementation on menopausal quality of life. Menopause. 2013;20(04):443–447 Doi: 10.1097/gme.0b013e318275025e https://doi.org/10.1097/gme.0b013e318275...
|
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx2 |
Grimaldi et al. (2012)2929 Grimaldi EF, Restaino S, Inglese S, Foltran L, Sorz A, Di Lorenzo G, et al. Role of highmolecular weight hyaluronic acid in postmenopausal vaginal discomfort. Minerva Ginecol. 2012;64(04): 321–329
|
fx3 |
fx3 |
fx3 |
fx2 |
fx3 |
fx2 |
fx2 |
Tedeschi and Benvenuti (2012)3535 Tedeschi C, Benvenuti CResearch Group EG. Comparison of vaginal gel isoflavones versus no topical treatment in vaginal dystrophy: results of a preliminary prospective study. Gynecol Endocrinol. 2012;28(08):652–654. Doi: 10.3109/09513590.2011.650764 https://doi.org/10.3109/09513590.2011.65...
|
fx3 |
fx3 |
fx2 |
fx2 |
fx3 |
fx2 |
fx2 |
Chen et al. (2013)6868 Chen J, Geng L, Song X, Li H, Giordan N, Liao Q. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel- group, clinical trial. J Sex Med. 2013;10(06):1575–1584. Doi: 10.1111/jsm.12125 https://doi.org/10.1111/jsm.12125...
|
fx3 |
fx3 |
fx1 |
fx1 |
fx3 |
fx3 |
fx3 |
Lima et al. (2013)3636 Lima SM, Yamada SS, Reis BF, Postigo S, Galvão da SilvaMA, Aoki T. Effective treatment of vaginal atrophy with isoflavone vaginal gel. Maturitas. 2013;74(03):252–258. Doi: 10.1016/j.maturitas. 2012.11.012 https://doi.org/10.1016/j.maturitas.2012...
|
fx2 |
fx2 |
fx2 |
fx2 |
fx3 |
fx3 |
fx3 |
Portman et al. (2013)5353 Portman DJ, Bachmann GA, Simon JAOspemifene Study Group. Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy. Menopause. 2013;20(06):623–630. Doi: 10.1097/gme.0b013e318279ba64 https://doi.org/10.1097/gme.0b013e318279...
|
fx3 |
fx2 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
Zheng et al. (2013)3030 Zheng TP, Sun AJ, Xue W,Wang YP, Jiang Y, Zhang Y, et al. Efficacy and safety of Cimicifuga foetida extract on menopausal syndrome in Chinese women. Chin Med J (Engl). 2013;126(11):2034–2038
|
fx3 |
fx3 |
fx1 |
fx1 |
fx3 |
fx3 |
fx2 |
Constantine et al. (2015)5454 Constantine G, Graham S, Portman DJ, Rosen RC, Kingsberg SA. Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial. Climacteric. 2015;18(02): 226–232. Doi: 10.3109/13697137.2014.954996 https://doi.org/10.3109/13697137.2014.95...
|
fx2 |
fx2 |
fx2 |
fx2 |
fx3 |
fx3 |
fx2 |
Fernandes et al. (2014)1919 Fernandes T, Costa-Paiva LH, Pinto-Neto AM. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on sexual function in postmenopausal women: a randomized controlled trial. J Sex Med. 2014;11(05):1262–1270. Doi: 10.1111/jsm.12473 https://doi.org/10.1111/jsm.12473...
|
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx1 |
Labrie et al. (2014)4747 Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez Jet al. Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women. J Sex Med. 2014;11(07): 1766–1785 Doi: 10.1111/jsm.12517 https://doi.org/10.1111/jsm.12517...
|
fx2 |
fx2 |
fx2 |
fx2 |
fx3 |
fx3 |
fx2 |
Lima et al. (2014)3737 Lima SM, Bernardo BF, Yamada SS, Reis BF, da SilvaGM, GalvãoMA. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial. Maturitas. 2014;78(03):205–211. Doi: 10.1016/j.maturitas.2014.04.007 https://doi.org/10.1016/j.maturitas.2014...
|
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx2 |
Portman et al. (2014)5555 Portman D, Palacios S, Nappi RE, Mueck AO. Ospemifene, a nonoestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial. Maturitas. 2014;78(02):91–98. Doi: 10.1016/j.maturitas. 2014.02.015 https://doi.org/10.1016/j.maturitas.2014...
|
fx2 |
fx2 |
fx2 |
fx2 |
fx3 |
fx3 |
fx3 |
Archer et al. (2015)4848 Archer DF, Labrie F, Bouchard C, Portman DJ, KoltunW, Cusan L, et al; VVA Prasterone Group. Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone). Menopause. 2015;22(09):950–963. Doi: 10.1097/gme.00 00000000000428 https://doi.org/10.1097/gme.000000000000...
|
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
Bouchard et al. (2015)4949 Bouchard C, Labrie F, Archer DF, Portman DJ, KoltunW, Elfassi E, et al; VVA Prasterone Group. Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone onvulvovaginal atrophy. Climacteric. 2015;18(04):590–607. Doi: 10.3109/13697137.2014.992012 https://doi.org/10.3109/13697137.2014.99...
|
fx3 |
fx3 |
fx1 |
fx1 |
fx3 |
fx2 |
fx2 |
Goetsch et al. (2015)6565 Goetsch MF, Lim JY, Caughey AB. A practical solution for dyspareunia in breast cancer survivors: a randomized controlled trial. J Clin Oncol. 2015;33(30):3394–3400. Doi: 10.1200/jco.2014.60.7366 https://doi.org/10.1200/jco.2014.60.7366...
|
fx3 |
fx2 |
fx3 |
fx2 |
fx3 |
fx3 |
fx1 |
Labrie et al. (2015)5050 Labrie F, Derogatis L, Archer DF, Koltun W, Vachon A, Young D, et al; Members of the VVA Prasterone Research Group. Effect of intravaginal prasterone on sexual dysfunction in postmenopausal women with vulvovaginal atrophy. J Sex Med. 2015;12(12): 2401–2412. Doi: 10.1111/jsm.13045 https://doi.org/10.1111/jsm.13045...
|
fx3 |
fx3 |
fx2 |
fx2 |
fx3 |
fx3 |
fx2 |
Tungmunsakulchai et al. (2015)5757 Tungmunsakulchai R, Chaikittisilpa S, Snabboon T, Panyakhamlerd K, Jaisamrarn U, Taechakraichana N. Effectiveness of a low dose testosterone undecanoate to improve sexual function in postmenopausal women. BMC Womens Health. 2015;15:113. Doi: 10.1186/s12905-015-0270-6 https://doi.org/10.1186/s12905-015-0270-...
|
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx2 |
fx2 |
Hickey et al. (2016)2020 Hickey M, Marino JL, Braat S,Wong S. A randomized, double-blind, crossover trial comparing a silicone- versus water-based lubricant for sexual discomfort after breast cancer. Breast Cancer Res Treat. 2016;158(01):79–90. Doi: 10.1007/s10549-016-3865-1 https://doi.org/10.1007/s10549-016-3865-...
|
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx2 |
Jokar et al. (2016)3131 Jokar A, Davari T, Asadi N, Ahmadi F, Foruhari S. Comparison of the hyaluronic acid vaginal cream and conjugated estrogen used in treatment of vaginal atrophy of menopause women: a randomized controlled clinical trial. Int J Community Based Nurs Midwifery. 2016;4(01):69–78
|
fx3 |
fx3 |
fx1 |
fx1 |
fx3 |
fx3 |
fx3 |
Juliato et al. (2017)2121 Juliato PT, Rodrigues AT, Stahlschmidt R, Juliato CR, Mazzola PG. Can polyacrylic acid treat sexual dysfunction in women with breast cancer receiving tamoxifen? Climacteric. 2017;20(01): 62–66. Doi: 10.1080/13697137.2016.1258396 https://doi.org/10.1080/13697137.2016.12...
|
fx3 |
fx2 |
fx1 |
fx1 |
fx3 |
fx2 |
fx2 |
Labrie et al. (2016)5151 Labrie F, Archer DF, KoltunW, Vachon A, Young D, Frenette L, et al; VVA Prasterone Research Group. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Menopause. 2016;23 (03):243–256. Doi: 10.1097/gme.0000000000000571 https://doi.org/10.1097/gme.000000000000...
|
fx3 |
fx3 |
fx2 |
fx2 |
fx3 |
fx3 |
fx2 |
Melisko et al. (2017)5858 Melisko ME, Goldman ME, Hwang J, De Luca A, Fang S, Esserman LJ, et al. Vaginal testosterone cream vs estradiol vaginal ring for vaginal dryness or decreased libido in women receiving aromatase inhibitors for early-stage breast cancer: a randomized clinical trial. JAMA Oncol. 2017;3(03):313–319 Doi: 10.1001/jamaoncol.2016.3904 https://doi.org/10.1001/jamaoncol.2016.3...
|
fx3 |
fx2 |
fx1 |
fx1 |
fx3 |
fx2 |
fx2 |
Postigo et al. (2016)3838 Postigo S, Lima SM, Yamada SS, dos Reis BF, da Silva GM, Aoki T. Assessment of the effects of Tribulus terrestris on sexual function of menopausal women. Rev Bras Ginecol Obstet. 2016;38(03): 140–146. Doi: 10.1055/s-0036-1571472 https://doi.org/10.1055/s-0036-1571472...
|
fx3 |
fx2 |
fx3 |
fx2 |
fx3 |
fx2 |
fx2 |
Seyyedi et al. (2016)2222 Seyyedi F, Kopaei MR, Miraj S. Comparison between vaginal royal jelly and vaginal estrogen effects on quality of life and vaginal atrophy in postmenopausal women: a clinical trial study. Electron Physician. 2016;8(11):3184–3192. Doi: 10.19082/3184 https://doi.org/10.19082/3184...
|
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
De Souza et al. (2016)3939 de Souza KZ, Vale FB, Geber S. Efficacy of Tribulus terrestris for the treatment of hypoactive sexual desire disorder in postmenopausal women: a randomized, double-blinded, placebo-controlled trial. Menopause. 2016;23(11):1252–1256. Doi: 10.1097/gme.0 000000000000766 https://doi.org/10.1097/gme.000000000000...
|
fx3 |
fx3 |
fx3 |
fx2 |
fx3 |
fx2 |
fx3 |
Yaralizadeh et al. (2016)4040 Yaralizadeh M, Abedi P, Najar S, Namjoyan F, Saki A. Effect of Foeniculum vulgare (fennel) vaginal cream on vaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled trial. Maturitas. 2016;84:75–80. Doi: 10.1016/j.maturitas.2015.11.005 https://doi.org/10.1016/j.maturitas.2015...
|
fx3 |
fx2 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
Cruz et al. (2018)6363 Cruz VL, Steiner ML, Pompei LM, Strufaldi R, Fonseca FL, Santiago LH, et al. Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women. Menopause. 2018;25(01):21–28 Doi: 10.1097/GME.0000000000000955 https://doi.org/10.1097/GME.000000000000...
|
fx3 |
fx3 |
fx3 |
fx2 |
fx3 |
fx3 |
fx1 |
Malakouti et al. (2017)4141 Malakouti J, Jabbari F, Asghari-Jafarabadi M, Javadzadeh Y, Farshbaf- Khalili A. The impact of ginkgo biloba tablet and aromatherapy inhaler combination on sexual function in females during postmenopausal period: a double-blind randomized controlled trial. Int J Women's Health Reprod Sci. 2017;5(02):129–136. Doi: 10.15296/ijwhr.2017.24 https://doi.org/10.15296/ijwhr.2017.24...
|
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
Nappi et al. (2017)2323 Nappi RE, Cagnacci A, Becorpi AM, Nappi C, Paoletti AM, Busacca M, et al. Monurelle Biogel® vaginal gel in the treatment of vaginal dryness in postmenopausal women. Climacteric. 2017;20(05): 467–475 Doi: 10.1080/13697137.2017.1335703 https://doi.org/10.1080/13697137.2017.13...
|
fx3 |
fx3 |
fx1 |
fx1 |
fx3 |
fx2 |
fx2 |
Nazarpour et al. (2017)5959 Nazarpour S, Simbar M, Ramezani Tehrani F, AlaviMajd H. Effects of sex education and kegel exercises on the sexual function of postmenopausal women: a randomized clinical trial. J Sex Med. 2017;14(07):959–967. Doi: 10.1016/j.jsxm.2017.05.006 https://doi.org/10.1016/j.jsxm.2017.05.0...
|
fx3 |
fx1 |
fx1 |
fx2 |
fx3 |
fx3 |
fx2 |
Suwanvesh et al. (2017)4242 Suwanvesh N, Manonai J, Sophonsritsuk A, Cherdshewasart W. Comparison of Pueraria mirifica gel and conjugated equine estrogen cream effects on vaginal health in postmenopausal women. Menopause. 2017;24(02):210–215. Doi: 10.1097/gme.0000000000000742 https://doi.org/10.1097/gme.000000000000...
|
fx3 |
fx3 |
fx3 |
fx1 |
fx3 |
fx2 |
fx2 |
Diem et al. (2018)2424 Diem SJ, Guthrie KA, Mitchell CM, Reed SD, Larson JC, Ensrud KE, et al. Effects of vaginal estradiol tablets and moisturizer on menopause-specific quality of life and mood in healthy postmenopausal women with vaginal symptoms: a randomized clinical trial. Menopause. 2018;25(10):1086–1093 Doi: 10.1097/gme.0000000000001131 https://doi.org/10.1097/gme.000000000000...
|
fx3 |
fx3 |
fx3 |
fx2 |
fx3 |
fx2 |
fx2 |
Golmakani et al. (2019)6666 Golmakani N, Parnan Emamverdikhan A, Zarifian A, Sajadi Tabassi SA, Hassanzadeh M. Vitamin E as alternative local treatment in genitourinary syndrome of menopause: a randomized controlled trial. Int Urogynecol J Pelvic Floor Dysfunct. 2019;30(05): 831–837. Doi: 10.1007/s00192-018-3698-z https://doi.org/10.1007/s00192-018-3698-...
|
fx3 |
fx3 |
fx1 |
fx2 |
fx3 |
fx2 |
fx2 |
Mitchell et al. (2018)2525 Mitchell CM, Reed SD, Diem S, Larson JC, Newton KM, Ensrud KE, et al. Efficacy of vaginal estradiol or vaginal moisturizer vs placebo for treating postmenopausal vulvovaginal symptoms: a randomized clinical trial. JAMA Intern Med. 2018;178(05): 681–690 Doi: 10.1001/jamainternmed.2018.0116 https://doi.org/10.1001/jamainternmed.20...
|
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx2 |
Nazarpour et al. (2018)6060 Nazarpour S, Simbar M, Majd HA, Tehrani FR. Beneficial effects of pelvic floor muscle exercises on sexual function among postmenopausal women: a randomised clinical trial. Sex Health. 2018;15 (05):396–402. Doi: 10.1071/SH17203 https://doi.org/10.1071/SH17203...
|
fx3 |
fx2 |
fx1 |
fx1 |
fx3 |
fx3 |
fx2 |
Torky et al. (2018)6262 Torky HA, Taha A, Marie H, El-Desouky E, Raslan O, Moussa AA, et al. Role of topical oxytocin in improving vaginal atrophy in postmenopausalwomen: a randomized, controlled trial. Climacteric. 2018;21 (02):174–178 Doi: 10.1080/13697137.2017.1421924 https://doi.org/10.1080/13697137.2017.14...
|
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
Archer et al. (2019)5656 Archer DF, Goldstein SR, Simon JA, Waldbaum AS, Sussman SA, AltomareC, et al. Efficacyandsafetyofospemifene inpostmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial. Menopause. 2019;26(06):611–621Doi: 10.1097/GME.0000000000001292 https://doi.org/10.1097/GME.000000000000...
|
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx2 |
Ghorbani et al. (2019)4343 Ghorbani Z, Mirghafourvand M, Charandabi SM, Javadzadeh Y. The effect of ginseng on sexual dysfunction in menopausal women: A double-blind, randomized, controlled trial. Complement Ther Med. 2019;45:57–64. Doi: 10.1016/j.ctim.2019.05.015 https://doi.org/10.1016/j.ctim.2019.05.0...
|
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx2 |
fx3 |
Mitchell et al. (2019)2626 Mitchell CM, Guthrie KA, Larson J, Diem S, LaCroix AZ, Caan B, et al. Sexual frequency and pain in a randomized clinical trial of vaginal estradiol tablets, moisturizer, and placebo in postmenopausal women. Menopause. 2019;26(08):816–822 Doi: 10.1097/GME.0000000000001341 https://doi.org/10.1097/GME.000000000000...
|
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx2 |
fx2 |
Palma et al. (2019)4444 Palma F, Fontanesi F, Facchinetti F, Cagnacci A. Acupuncture or phy (F)itoestrogens vs. (E)strogen plus progestin on menopausal symptoms. A randomized study. Gynecol Endocrinol. 2019;35 (11):995–998. Doi: 10.1080/09513590.2019.1621835 https://doi.org/10.1080/09513590.2019.16...
|
fx3 |
fx2 |
fx2 |
fx2 |
fx3 |
fx3 |
fx2 |
Politano et al. (2019)6464 Politano CA, Costa-Paiva L, Aguiar LB, Machado HC, Baccaro LF. Fractional CO2 laser versus promestriene and lubricant in genitourinary syndrome of menopause: a randomized clinical trial. Menopause. 2019;26(08):833–840. Doi: 10.1097/GME.0000000000001333 https://doi.org/10.1097/GME.000000000000...
|
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |
fx3 |